<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>SignPost Cancer Analytics</title><description>Publications, press, presentations, and updates.</description><link>https://signpostcanceranalytics.com/</link><language>en-us</language><item><title>SignPost and Weill Cornell Medicine to conduct pilot study of BreastDefense analytical performance</title><link>https://signpostcanceranalytics.com/news/weill-cornell-pilot-study/</link><guid isPermaLink="true">https://signpostcanceranalytics.com/news/weill-cornell-pilot-study/</guid><description>SignPost Cancer Analytics</description><pubDate>Fri, 25 Sep 2026 00:00:00 GMT</pubDate><category>Press</category></item></channel></rss>